Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) Solicitation
Award Notice Posted
- Solicitation number
- 75D30124D20078
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D3012420078-75D30124F00001
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Burlington, North Carolina, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) has awarded a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) contract to Laboratory Corporation of America for $75,750 to establish a task order for developing and validating an Influenza A/H5 assay. The objective is to ensure preparedness for Influenza A (H5) outbreaks and refine rapid response processes for future public health emergencies. This contract aims to provide the CDC with advanced diagnostic testing capacity for addressing outbreaks or pandemics caused by Pathogens of Pandemic Potential.
Notice text
The CDC’s objective is to establish a task order with a source or sources equipped with advanced diagnostic testing capacity for addressing outbreaks or pandemics caused by Pathogens of Pandemic Potential (PPP). The contractors shall be tasked with developing and validating an Influenza A/H5 assay. This initiative aims to ensure preparedness for Influenza A (H5) outbreaks and to refine rapid response processes for future public health emergencies in the event of an epidemic or pandemic.
Awarded contract 75D3012420078 to LABORATORY CORPORATION OF AMERICA for 75750.00 on 2024-09-06.
Notice history
6 of 12 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity